Stock listing

Bio-techne Corp

Selected listing: T1CH34 · BMFBOVESPA · BRL · BR

Bio-techne Corp (B3:T1CH34), Health Technology. Latest release Sep 23, 2026: Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany.

T1CH34:BMFBOVESPABRLBRUpdated September 25, 2026

Ticker: B3:T1CH34
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: B3
Currency: BRL

About Bio-techne Corp

The company specializes in providing high-quality biotech products and services. Bio-techne is committed to advancing scientific research and improving patient outcomes through innovative solutions in the life sciences sector.

Latest news from Bio-techne Corp

Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany

September 23, 2026

Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration

September 22, 2026

Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals

September 1, 2026

Bio-Techne Corrects Dividend Announcement

August 13, 2026

Bio-Techne Releases Fourth Quarter Fiscal 2026 Results

August 12, 2026

All Bio-techne Corp news →

Events

Replays

Bio-Techne Corp (TECH) Q3 2026 Earnings Call
Wed, May 06, 2026 · 09:00 AM ET
Watch
Bio-Techne Corp (TECH) Q2 2026 Earnings Call
Wed, Feb 04, 2026 · 09:00 AM ET
Watch
Bio-Techne Corp (TECH) Q1 2026 Earnings Call
Wed, Nov 05, 2025 · 09:00 AM ET
Watch

Research Bio-techne Corp

Bio-techne Corp company profile

View the public company page for Bio-techne Corp on 6ix.

Bio-techne Corp news

Read company news and market updates connected to Bio-techne Corp.

Bio-techne Corp investor events

Find investor webinars, events, and replay context for Bio-techne Corp.